Company
A2 Biotherapeutics
CREATING THE FUTURE OF PRECISION IMMUNOTHERAPIES
Also known as A2 Bio
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- A2 Biotherapeutics
- a2biotherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are advancing our Tmod™ cell engineering platform to create precision CAR T-cell therapies. Our mission is to restore health and hope for people living with cancer and other devastating diseases.
Funding snapshot
- Total raised
- $208MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series C, $80M2025-01-09
Funding rounds
- Series C
- $80M2025-01-09, Company stated
- Series B
- $71.5M2020-10-06, Company stated
- Series A
- $57M2019-11-05, Company stated
Loading relationship preview